Evaluation of Boric Acid Treatment on microRNA-127-5p and Metastasis Genes Orchestration of Breast Cancer Stem Cells
- PMID: 38963646
- PMCID: PMC11872770
- DOI: 10.1007/s12011-024-04274-6
Evaluation of Boric Acid Treatment on microRNA-127-5p and Metastasis Genes Orchestration of Breast Cancer Stem Cells
Abstract
Coregulation of microRNAs (miRNAs) and cancer stem cells (CSCs) is very important in carcinogenesis. miR-127-5p is known to be downregulated in breast cancer. In this study, we aimed to investigate how boric acid (BA), known for its previously unstudied anti-cancer properties, would affect the expression of miR127-5p and genes responsible for breast cancer stem cells (BC-SCs) metastasis. BC-SCs were isolated from human breast cancer cells (MCF-7) by immunomagnetic cell separation and characterized with flow cytometry and sphere formation. The viability of BC-SCs and the determination of its IC50 value in response to boric acid (BA) were assessed via the MTT assay. Boric acid exhibited dose- and time-dependent inhibition of cell viability in cells. The IC50 doses of boric acid in MCF-7 cells and BC-SCs were 45.69 mM and 41.27 mM, respectively. The impact of BA on the expression of metastatic genes and miR127-5p was elucidated through RT-qPCR analysis. While the expression of the COL1A1 (p < 0.05) and VIM (p < 0.01) was downregulated, the expression of the miR-127-5p, ZEB1 (p < 0.01), CDH1 (p < 0.05), ITGB1 (p < 0.05), ITGA5 (p < 0.05), LAMA5 (p < 0.01), and SNAIL (p < 0.05), was up-regulated in dose-treated BC-SCs (p < 0.001) to the RT-qPCR results. Our findings suggest that boric acid could induce miR-127-5p expression. However, it cannot be said that it improves the metastasis properties of breast cancer stem cells.
Keywords: Boric acid; Breast cancer; Cancer stem cell; Metastasis; miR-127-5p.
© 2024. The Author(s).
Conflict of interest statement
Declarations. Ethical Approval: No ethical approval is required. Competing Interests: The authors declare no competing interests.
Figures





Similar articles
-
Boric Acid Alters the Expression of DNA Double Break Repair Genes in MCF-7-Derived Breast Cancer Stem Cells.Biol Trace Elem Res. 2024 Sep;202(9):3980-3987. doi: 10.1007/s12011-023-03987-4. Epub 2023 Dec 12. Biol Trace Elem Res. 2024. PMID: 38087035
-
The analysis of boric acid effect on epithelial-mesenchymal transition of CD133 + CD117 + lung cancer stem cells.Naunyn Schmiedebergs Arch Pharmacol. 2024 Sep;397(9):6791-6802. doi: 10.1007/s00210-024-03062-2. Epub 2024 Mar 27. Naunyn Schmiedebergs Arch Pharmacol. 2024. Retraction in: Naunyn Schmiedebergs Arch Pharmacol. 2025 Jan;398(1):1027. doi: 10.1007/s00210-024-03613-7. PMID: 38536434 Free PMC article. Retracted.
-
Boric Acid Affects the Expression of DNA Double-Strand Break Repair Factors in A549 Cells and A549 Cancer Stem Cells: An In Vitro Study.Biol Trace Elem Res. 2024 Nov;202(11):5017-5024. doi: 10.1007/s12011-024-04082-y. Epub 2024 Feb 17. Biol Trace Elem Res. 2024. PMID: 38367174 Free PMC article.
-
MicroR-760 suppresses cancer stem cell subpopulation and breast cancer cell proliferation and metastasis: By down-regulating NANOG.Biomed Pharmacother. 2016 May;80:304-310. doi: 10.1016/j.biopha.2016.03.024. Epub 2016 Apr 5. Biomed Pharmacother. 2016. PMID: 27133070
-
MicroRNA-205-5p inhibits the growth and migration of breast cancer through targeting Wnt/β-catenin co-receptor LRP6 and interacting with lncRNAs.Mol Cell Biochem. 2025 Apr;480(4):2117-2129. doi: 10.1007/s11010-024-05136-4. Epub 2024 Oct 26. Mol Cell Biochem. 2025. PMID: 39461917 Review.
References
-
- Hussen BM et al (2021) MicroRNA: a signature for cancer progression. Biomed Pharmacother 138:111528 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous